Pieter Elbers' Playbook for Turning IndiGo Into a Global Carrier
Leaders of Travel: Skift C-Suite Series What are the top trends impacting hotels, airlines, and online bookings? We speak to the executives shaping the future of travel.
What are the top trends impacting hotels, airlines, and online bookings? We speak to the executives shaping the future of travel.
Learn More
Already India's largest airline, IndiGo hired Pieter Elbers to accelerate its expansion. Under his watch as chief executive, the company is ramping up its international growth as it transitions from being a regional player into a major cross-border carrier.
More than 100 long-haul aircraft are on the way. IndiGo has 60 A350-900 widebodies on firm order, plus more than 60 A321XLRs – the latter due to join the fleet before the end of the year. Hundreds more short and medium-haul jets are also in the pipeline.
The airline is eager to expand, but it didn't want to wait for the factory-fresh A350s to be delivered.
As a short-term workaround, the airline is leasing 787 Dreamliner jets from European carrier Norse Atlantic. These on-loan planes allowed IndiGo to start flights to Amsterdam and Manchester earlier this month.
Airline Business 101
Speaking to Skift in Manchester, Elbers opened the conversation with a quick reminder – costs determine the airfare and an airline's positioning in the market. More typical short-haul IndiGo routes see an à la carte offering. It's a 'pay what you use' approach adopted by countless carriers around the world.
However, the nature of IndiGo's intercontinental network expansion requires a different approach. It's what Elbers calls his 'fit-for-purpose' product development methodology. 'At
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
28 minutes ago
- Yahoo
Vedanta's Q1 Adjusted Profit Surges 10% to $584 million
MUMBAI, India, Aug. 6, 2025 /PRNewswire/ -- India based, Vedanta Limited (BSE: 500295 & NSE: VEDL), the country's leading critical minerals, transition metals, energy & technology conglomerate announced its results for the first quarter ended 30th June 2025 on 31st July 2025. Vedanta delivered robust financials with adjusted PAT* jumping 10% year-on-year (YoY) to $ 584 million. The company clocked the highest ever first quarter EBITDA of $1.3 billion, up 2% YoY. Vedanta's EBITDA margin** improved by 81 bps to 35% YoY, highest in the last 13 quarters. The company's consolidated revenue for Q1 stood at $4.4 billion, up 4% YoY. Vedanta's liquidity improved 29% YoY with cash and cash equivalent of $2.6 billion. The company's Return on Capital Employed (ROCE) improved by 87 bps YoY to 25%. Credit ratings for Vedanta were reaffirmed at AA by both CRISIL and ICRA. Prominent brokerages such as Citi, Investec, JP Morgan, Bank of America (BofA) have maintained their ratings and forecast strong earnings growth during FY26 and FY27 highlighting market confidence in Vedanta's growth story. Anil Agarwal - Chairman Vedanta, said, "Our Q1FY26 performance has set a strong foundation for the year ahead. Even amidst global market volatility, we delivered strong broad-based performance and long-term value creation." The company clocked record quarterly alumina production at 587 KT, up 9% YoY with lowest hot metal cost (ex-alumina) at 888 $/t in the last 16 quarters and overall aluminum cost of production lower by 12% QoQ. Vedanta's zinc operations in India achieved highest ever Q1 mined metal production and lowest Q1 cost of production at US$1,010/t. The company's international zinc operations witnessed a 50% YoY jump in mined metal production with overall cost of production at $1269/t. The company also recently commissioned 950 MW of merchant power capacity in its two thermal power plants in the eastern state of Chhattisgarh and southern state of Andhra Pradesh. About Vedanta: Vedanta is a global leader in critical minerals, transition metals, energy, and technology, with operations spanning India, South Africa, Namibia, Liberia, UAE, Saudi Arabia, Korea, Taiwan, and Japan. Visit - USD-INR exchange rate of 85.57 *PAT Adjusted for key one-offs: Cairn OALP Exploration cost written off (net of tax) in 1QFY26 and 4QFY25 and DTA of unutilized tax losses at ASI in 1QFY25 **EBITDA margin (ex-copper) View original content: SOURCE Vedanta Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
28 minutes ago
- Yahoo
Tata's acquisition of IVECO: a defining moment for Europe's commercial vehicle sector
Truck industry observers have long speculated about the first takeover of a European OEM by an Asian Group—with IVECO, following the spin-off from CNH Industrial in 2022, very much in the focus of the speculation. The historic moment arrived with the announcement of Tata Motors' €3.8 billion ($4.4 billion) all cash voluntary tender offer to acquire IVECO's Commercial Vehicle business (excluding its defence division), on July 30, 2025. The transaction is contingent on the sale of IVECO's defence arm, Iveco Defence Vehicles (IDV), which is being divested separately to Leonardo SpA for €1.7 billion ($2.0 billion). Completion is expected by early 2026. The planned arrangement aims to preserve IVECO's autonomy: its headquarters remain in Turin, its workforce and industrial footprint are protected by binding non-financial covenants (no layoffs, and no plant closures for at least two years), and the existing board structure will be largely retained with independent oversight. Once complete, the deal will create a global Commercial Vehicle powerhouse, with combined annual revenues of around €22 billion ($26 billion) and a global production footprint spanning Europe, Asia, and Latin America. According to GlobalData's analysis, the merger will create a new grouping on a par with TRATON and Volvo Group in terms of global Truck market share and annual production capacity. Indeed, a combination of US market decline and stable demand in India has resulted in a regional rebalancing that would have driven up Tata/IVECO's combined share of the global market (excluding China) to near the top of the ranking during the first half of 2025—second only to global market leader, Daimler. From a product and geographical viewpoint, Tata's dominance in India and Southeast Asia is highly complementary to IVECO's presence in Europe and Latin America, with no significant overlap in product lines or manufacturing geography. As IVECO and Tata compete in different markets, there is little danger in this scenario of a combined market share erosion. The geographical spread distinguishes it from previous European Heavy-Duty (HD) mergers (MAN/Scania, Volvo/Renault). Tata also gains access to IVECO's FPT Industrial powertrain technologies, including electric, hydrogen, and natural-gas platforms, providing it with scope to expand its net zero ambitions. From a strategic point of view, the acquisition is transformative in elevating Tata from a predominantly regional player to a genuine global OEM, with immediate access to European and Latin American markets and distribution networks. In the longer term, combining R&D, procurement and production across regions will also potentially enable better cost leverage and smoother responses to cyclical demand swings across global Commercial Vehicle markets. The acquisition of IVECO marks a watershed moment for Tata Motors and represents the most significant strategic realignment of the European Truck industry since the merger of Scania and MAN under the TRATON umbrella in 2021: the first takeover of a major European Truck OEM by an Asian group. While Asian manufacturers have, thus far, expanded globally through greenfield ventures or partnerships, none have previously acquired a top-tier European Commercial Vehicle brand outright. IVECO, with its deep engineering roots in Italy, Germany, and Spain, and a legacy dating back over a century, is one of Europe's core industrial Truck manufacturers. The move reflects the growing confidence and capital strength of Asian industrial groups, particularly India's Tata Group, with two landmark automotive acquisitions in Europe—first with Jaguar Land Rover in 2008, and now IVECO in 2025. It also signals a shift in global Truck market dynamics, as Asian players move from regional dominance to global consolidation. The implications are far-reaching: cross-continental technology transfer, access to EU markets, and potentially new alliances in alternative powertrains are now all firmly on the horizon. Zita Zigan, Director, Global Commercial Vehicle Forecasts This article was first published on GlobalData's dedicated research platform, the . "Tata's acquisition of IVECO: a defining moment for Europe's commercial vehicle sector" was originally created and published by Just Auto, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
28 minutes ago
- Yahoo
Why Novo Nordisk Stock Is Down Again Today
Key Points Novo Nordisk stock missed earnings a week ago and warned of slowing growth. Competition from drug compounding firms and from rival Eli Lilly is eating into Novo's market share. The stock keeps getting cheaper, but its growth rate and dividend yield remain good. 10 stocks we like better than Novo Nordisk › Shares of Novo Nordisk (NYSE: NVO), the Danish pharmaceuticals company famed for its Ozempic and Wegovy weight loss drugs, collapsed after reporting earnings a week ago -- and it's been mostly a downhill slide since. The stock's down again today, bringing cumulative losses to 31%. This time, you can blame UBS. What UBS says about Novo Nordisk UBS analyst Matthew Weston removed his buy rating on Novo Nordisk stock this morning, downgrading the shares to neutral and setting a price target of about $52.77, as Street Insider reports. In last week's earnings report, you see, Novo dismissed worries that competition from drug compounding firms, making and selling cheaper versions of Ozempic under their own names, is a significant threat from its business -- but UBS begs to differ. "Following expert channel checks, we expect GLP1 compounders to remain in the US, which limits cash-pay uptake and leaves an uncertain outlook for US Wegovy," warned Weston. At the same time, the analyst says Novo is continuing to lose market share to rival Eli Lilly (NYSE: LLY) and its own weight loss drugs such as Mounjaro. Is Novo Nordisk stock a sell? Weston's downgrade still values Novo Nordisk stock above its current share price of $47 and change, however. Moreover, Novo Nordisk stock currently costs less than 14 times earnings. Although Weston warns that sales growth is slowing to perhaps 6% in the second half of the year from 18% in the first half, that still averages out to about a 12% annual growth rate -- perhaps not explosive, but still respectable. And between the growth rate and the 3.3% dividend, we're looking at a total return of more than 15% on this stock, which makes a 14 P/E ratio look cheap. Despite (or even because of?) the falling share price, I'd still be a buyer of Novo Nordisk stock. Should you invest $1,000 in Novo Nordisk right now? Before you buy stock in Novo Nordisk, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Novo Nordisk wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $631,505!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,103,313!* Now, it's worth noting Stock Advisor's total average return is 1,039% — a market-crushing outperformance compared to 181% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 4, 2025 Rich Smith has no position in any of the stocks mentioned. The Motley Fool recommends Novo Nordisk. The Motley Fool has a disclosure policy. Why Novo Nordisk Stock Is Down Again Today was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
